Biomarkers – Webinars and Online Events

In this webinar, our expert speaker will present a new approach – using nanopore adaptive sampling for comprehensive methylation profiling.

This webinar explores how non-invasive proteomic biomarkers enable personalized treatment and deeper disease insights. Plus, learn about a platform that measures 11,000 proteins to accelerate biomarker discovery.

Meaningful biomarker studies that account for genetic, environmental and lifestyle variation, or comprise of complex signatures from multiple proteins, require large cohorts – too large for the current proteomics discovery platforms.

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.

This webinar highlights a platform that can identify biomarkers with clinical benefit in non-small cell lung cancer and analyze the immune microenvironment in bone marrow trephine samples.

In this webinar, you’ll hear how automated liquid handling for LC-MS/MS sample preparation contributed to the identification and quantification of over 30 metabolites that can predict adverse pregnancy outcomes, including pre-eclampsia.

In this webinar, our speaker will discuss the role of glucosyl and galactosyl ceramides as biomarkers and how their misregulation can be an identifier for various disease states including, but not limited to, Parkinson’s, Krabbe and Gaucher diseases.

Dr. Walker explores how multi-modal biomarkers—from proteomics to brain imaging—can reveal blood-based indicators and therapeutic targets in individuals who later develop dementia.

This popular online event will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

This webinar presents a high-throughput proteomics platform used to identify proteins linked to ovarian cancer. A 22-protein model accurately distinguishes cancer cases from benign controls.